Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
2:09PMiHub NewswireFeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program
06/26/20243:40AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
06/26/20243:40AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
06/25/20244:05AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
06/25/20244:05AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
06/25/20242:05AMRNS Regulatory NewsAstraZeneca PLC Update on Imfinzi ADJUVANT BR.31 trialLSE:AZNAstrazeneca Plc
06/25/20242:00AMRNS Regulatory NewsAstraZeneca PLC Imfinzi improved EFS and OS in bladder cancerLSE:AZNAstrazeneca Plc
06/20/20245:56AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
06/20/20245:56AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
06/18/20244:33AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
06/18/20244:33AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
06/18/20242:00AMRNS Regulatory NewsAstraZeneca PLC Update on CAPItello-290 Phase III trialLSE:AZNAstrazeneca Plc
06/17/20244:09AMAlliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
06/17/20244:09AMAlliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
06/17/20242:23AMAlliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
06/17/20242:23AMAlliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
06/17/20242:00AMRNS Regulatory NewsAstraZeneca PLC Imfinzi approved in the US for endometrial cancerLSE:AZNAstrazeneca Plc
06/12/20243:56PMAlliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
06/12/20243:56PMAlliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
06/12/202410:00AMRNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
06/10/20243:30AMAlliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
06/10/20243:30AMAlliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
06/05/20244:27AMAlliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
06/05/20244:27AMAlliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
06/05/20242:00AMRNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
06/04/20247:00AMPR Newswire (US)AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024LSE:AZNAstrazeneca Plc
06/03/202410:05AMRNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
06/03/202410:00AMRNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
06/03/20243:59AMAlliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
06/03/20243:59AMAlliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

Delayed Upgrade Clock